In head and neck cancers, the neutrophil-to-lymphocyte ratio7, albumin level, and C-reactive protein level in the blood have recently attracted attention as biomarkers for the prediction of therapeutic efficacy and prognosis but are currently used only for reference. Here, ALB is linked to head and neck cancer.